TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

Personalized
Product Support

A free program to help you every
step of the way

Niki, a OnePath® Patient Support Manager, talking on the phone Niki, a OnePath® Patient Support Manager, talking on the phone
Niki

Here are just a few ways that OnePath can help:

Patient support manager icon
A dedicated Patient Support Manager
A single point of contact who is ready to assist you with your product support needs
Financial assistance information icon
Financial assistance options
Co-pay assistance for those who are eligible*, as well as assistance with navigating insurance coverage
Specially trained nurse icon
Injection training
In-home training from a specially trained nurse for you and/or a caregiver on how to self-administer TAKHZYRO
Education resources icon
Resources and education
Connecting you and your caregiver with educational resources

If you are enrolled in OnePath, you may use the free OnePath Mobile App to connect with OnePath and track your health in a personal eDiary.

*At a minimum to be eligible, patients must have commercial insurance. Other terms and conditions apply. Contact OnePath for more information.

To learn more, contact a OnePath Patient Support Manager at 1–866–888–0660 Monday through Friday, 8:30 am to 8:00 pm ET.

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

  • wheezing
  • difficulty breathing
  • chest tightness
  • fast heartbeat
  • faintness
  • rash
  • hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1-800-FDA-1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.